CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50335/143981_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| ![](/images/43908/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43908/101577_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25274/55630_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | ![](/images/13500/ihc_cell_selected_60x60.jpg) | ![](/images/13500/30420_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CHDH | Choline dehydrogenase | Enzymes Mitochondrial proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36633/81337_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42348/146593_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/2609/6566_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CLNK | Cytokine-dependent hematopoietic cell linker | | | ![](/images/35671/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35672/74689_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/43674/ihc_cell_selected_60x60.jpg) | ![](/images/43674/99425_A_5_6_rna_selected_60x60.jpg) | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31583/70634_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | ![](/images/17742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17742/39381_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9426/25394_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49331/111804_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
EXOC3L2 | Exocyst complex component 3-like 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41595/90149_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
FLRT3 | Fibronectin leucine rich transmembrane protein 3 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56033/141688_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_A_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103736_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48934/119479_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48934/119479_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/35231/124722_B_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/2083/7452_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
HOXA9 | Homeobox A9 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/61982/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/61982/139439_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
HOXC10 | Homeobox C10 | Transcription factors
| ![](/images/53919/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/53919/136216_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32443/80277_B_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
IL17RB | Interleukin 17 receptor B | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5482/15813_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Transcription factors
| ![](/images/43160/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43160/93427_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16702/37237_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15363/36296_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/64792/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64792/146055_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/13/117_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35555/67640_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | ![](/images/52497/if_selected_60x60.jpg) | ![](/images/52497/ihc_cell_selected_60x60.jpg) | ![](/images/52497/126993_B_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/28407/59771_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PALM3 | Paralemmin 3 | | | ![](/images/52794/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/52794/128141_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PARD6B | Par-6 family cell polarity regulator beta | | ![](/images/13376/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/13376/32583_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6277/18455_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PDZK1 | PDZ domain containing 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/5755/20350_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34376/117526_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/62558/140926_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38723/81034_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25903/56318_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
RENBP | Renin binding protein | Enzymes
| | | ![](/images/428/ihc_cell_selected_60x60.jpg) | ![](/images/522/904_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/922/1747_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins
| | ![](/images/24264/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/22009/49638_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
SFXN2 | Sideroflexin 2 | Mitochondrial proteins Predicted membrane proteins
| | ![](/images/26834/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18150/41315_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
SIM2 | Single-minded family bHLH transcription factor 2 | Transcription factors
| ![](/images/29295/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29295/64239_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47612/111052_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SLC2A9 | Solute carrier family 2 (facilitated glucose transporter), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66229/150480_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38360/79763_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |